Peripheral Insulin Resistance signifies a diminished capacity of skeletal muscle and adipose tissue—the primary peripheral tissues—to respond effectively to circulating insulin signals for glucose uptake and storage. This necessitates higher levels of circulating insulin (hyperinsulinemia) to maintain euglycemia, representing a central failure in metabolic control. It is a hallmark of prediabetes.
Origin
This term has its roots in early diabetes research, differentiating the tissue-specific defect from pancreatic beta-cell failure. The focus on “peripheral” tissue separates it from potential hepatic insulin resistance, although all are interconnected components of metabolic syndrome. It quantifies a major failure in substrate utilization.
Mechanism
The mechanism involves impaired translocation of GLUT4 transporters to the cell membrane due to chronic inflammation or lipid overload within the myocytes and adipocytes. This cellular blockade prevents insulin from efficiently facilitating glucose entry, forcing the pancreas to overcompensate. Addressing this resistance requires improving cellular health and reducing chronic inflammatory signaling that interferes with the insulin receptor cascade.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.